Hungary’s largest medical training institution
Semmelweis University’s Faculty of Medicine and Dentistry are the largest faculties of their kind in the country. Nearly 5,500 students are enrolled in the two faculties alone, of which almost 50% are international students.
According to the Times Higher Education (THE), Semmelweis University is one of the world’s most international universities. Almost one fourth of the more than 10,000 students are foreign, coming from about 70 countries of five continents. The university has partnerships with a total of more than 200 foreign – European, Asian and American – higher education institutions in a wide range of cooperation areas.
One of the highest performing Hungarian institutions in international rankings
Semmelweis University ranked 254th on the Quacquarelli Symonds (QS) World University Rankings list in 2018, making it the best of the Hungarian higher education institutions in the category of life and medical sciences education. In the more specialized fields of pharmacology and medicine, the university ranked among the world’s 200 best institutions.
Semmelweis ranked among the top 500 universities in the world according to the Times Higher Education (THE) 2018 global ranking system, the highest ranking achieved by any domestic higher education institution. In 2017, Semmelweis University reached an even higher ranking in the categories of life and medical health sciences, landing among the top 400 worldwide.
A combined imaging and operating room, called hybrid operating room can be foundat the University’s Varosmajor Heart and Vascular Centre, which is the only one of its kind in the entire region of Central Europe. Any kind of cardiovascular surgical and/or catheter procedure can be performed simultaneously with the same equipment without having to transfer the patient.
The University’s Department of Anatomy, Histology and Embryology is home to an internationally unique brain tissue bank and laboratory, established by professor emeritus Dr. Miklós Palkovits. This tissue bank provides the necessary samples for research conducted within the National Brain Research Program.
Hungary’s sole conductor training programme is offered by András Pető Faculty and conductive education of children and adults is only available at the faculty’s training sites.The Pető method won the first intellectual Hungaricum title in 2006 , and it received the Hungarian Heritage Prize in 2013 for its originality and uniqueness.
Many surgical interventions in Hungary were first performed at Semmelweis University. The first successful kidney transplantation (1973), liver transplantation (1995) and heart transplantation (1992). It was also home to the country’s first artificial heart implantation (2012), the first Hungarian catheterized heart valve surgery (2015), and the first keyhole surgical procedure for a child with oesophageal blockage (2016).
Semmelweis University is one of the largest health care institutions in Hungary. 200,000 outpatients and 10,500 are received in its institutes and clinics in the 4 clinical units (Inner Clinical Block, Outside Clinical Block, Kútvölgy Clinical Block, Városmajor Clinical Block) and in nearly 40 separate units . In 2016, Semmelweis University handled 122,000 cases of 91,000 inpatients and 2.4 million cases of 290,000 outpatients, accounting for about six percent of the health care needs of the Hungarian population.
According to indicators, the scientific publication activity of Semmelweis University is the most significant in its own field among higher education institutions in Hungary. The number of scientific publications per year is about one thousand, and their impact on scientific public opinionmeasured by number of references, is 16,000 for a five-year period. The ratio of quality publications is the highest among all Hungarian universities. The percentage of high prestige publications, which are published in the top 10% of scientific journals in the world was 34% in 2016.
Hungary’s most well-known and popular drug, Selegiline is related to the work of pharmaceutical researcheres of Semmelweis University. It is used in most countries of the world, especially in patients with Parkinson’s disease. The drug was developed thanks to key contributions by the university’s two professors emeritus: Dr. József Knoll and Dr. Kálmán Magyar.